MIG
LUMO

Mariner Investment Group’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Mariner Investment Group’s Portfolio LUMO Stock Details LUMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-1,111
Closed -$182K – 179
2016
Q1 		$182K Hold
1,111
– – 0.05% 147
2015
Q4 		$364K Buy
+1,111
New +$362K 0.08% 157

Other funds holding LUMO

First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
TAM
Tiverton Asset Management Wilimington, Delaware $2.88B AUM 5.6% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BIM
Bogle Investment Management Newton Lower Falls, Massachusetts $63M AUM 51.97% 1-Year Est. Return

Mariner Investment Group's LUMO Position: Q2 2016 in Review

Mariner Investment Group sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q2 2016, closing a stake of 1,111 shares — an estimated $182K sold.

Mariner Investment Group first reported a position in LUMO in Q4 2015 and held it in 2 quarters. The position peaked at $364K in Q4 2015. 112 funds tracked by Wall St. Rank hold LUMO as of Q2 2016.

  • Mariner Investment Group reported no remaining Lumos Pharma, Inc. Common Stock position as of Q2 2016 after selling out during the quarter.
  • Mariner Investment Group sold 1,111 Lumos Pharma, Inc. Common Stock shares in Q2 2016, an estimated $182K.
  • Mariner Investment Group first reported a position in Lumos Pharma, Inc. Common Stock in Q4 2015 and held it in 2 quarters.
  • Mariner Investment Group's Lumos Pharma, Inc. Common Stock position peaked at $364K in Q4 2015.
  • 112 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q2 2016.

Based on Mariner Investment Group's 13F filing for Q2 2016, filed 3 Aug 2016.